LEADER 03212nam 2200601 a 450 001 9910830334403321 005 20230617035718.0 010 $a1-282-34867-1 010 $a9786612348679 010 $a0-470-69595-1 010 $a0-470-69520-X 035 $a(CKB)1000000000687518 035 $a(EBL)470086 035 $a(SSID)ssj0000354200 035 $a(PQKBManifestationID)11264302 035 $a(PQKBTitleCode)TC0000354200 035 $a(PQKBWorkID)10302438 035 $a(PQKB)10238596 035 $a(MiAaPQ)EBC470086 035 $a(OCoLC)232612136 035 $a(EXLCZ)991000000000687518 100 $a20090715d2005 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aFighting infection in the 21st century$b[electronic resource] /$fedited by P.W. Andrew ... [et al.] 210 $aHoboken, N.J. $cWiley-Blackwell$d2005 215 $a1 online resource (286 p.) 300 $aDescription based upon print version of record. 311 $a0-470-69596-X 311 $a0-632-05817-X 320 $aIncludes bibliographical references. 327 $aFighting Infection in the 21st Century; Contents; The global threat of emerging infectious diseases; Can molecular techniques be used in the prevention of contamination of processed food by pathogens?; Is global clean water attainable?; Vaccine development: past, present and future; Live attenuated vectors: have they delivered?; New malaria vaccines: the DNA-MVA prime-boost strategy; Prospects for new and rediscovered therapies: probiotics and phage; Vaccine production in plants 327 $aConserved epitopes in bacterial lipopolysaccharides and cross-reactive antibodies in the treatment of endotoxicosis and Gram-negative septic shockBiological terrorism; Characterization of bacterial isolates with molecular techniques: multilocus sequence typing; Lessons from the first antibiotic era; New strategies for identifying and developing novel vaccines: genome-based discoveries; Are molecular methods the optimum route to antimicrobial drugs?; Index 330 $aThe 20th century has seen improvements in both public health and disease prevention which, in turn, have had a dramatic impact on our lives. Success in preventing infection by vaccination and treating infection with antibiotics led some to believe that infectious disease was a thing of the past. However, the adaptability of pathogens and the emergence of new diseases has presented microbiologists with a fresh set of challenges as we enter the new millennium. While celebrating past successes and highlighting developing problems, this volume aims to address some of the issues facing microbiologi 606 $aCommunicable diseases 606 $aAnti-infective agents 606 $aVaccines 615 0$aCommunicable diseases. 615 0$aAnti-infective agents. 615 0$aVaccines. 676 $a579 676 $a616.9 701 $aAndrew$b P. W$01615766 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910830334403321 996 $aFighting infection in the 21st century$93946114 997 $aUNINA